SPARK PATH SPARK THERAPEUTICS PIONEERING ACCESS TO HEALTHCARE
Live / Registered — Registered (as of 30 Apr 2024)
What this means for you
Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87812913
- Registration number
- 7369941
- Mark type
- Stylized text
- Filed
- 27 Feb 2018
- Published for opposition
- 13 Feb 2024
- Registered
- 30 Apr 2024
- Attorney of record
- Edward Frederick Behm
Goods and services
- Class 036 — Insurance and financial services: Providing information for patients, families and health care providers about health care insurance coverage, insurance reimbursement programs, insurance payer policies and patient financial assistance programs
- Class 045 — Legal and security services: Health care case management advice and consultation services, namely, care coordination for patients and families and providing advice, information and assistance to patients and their families in dealing with medical service providers, hospitals, insurance companies, and others involved in patient care
Owner
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
Prior registrations
Prosecution history
- 04 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Feb 2024 — PUBLISHED FOR OPPOSITION
- 24 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Apr 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Apr 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Apr 2023 — NON-FINAL ACTION E-MAILED
- 18 Apr 2023 — NON-FINAL ACTION WRITTEN